Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Director/PDMR Shareholding

9 May 2011 07:00

RNS Number : 1659G
Biome Technologies PLC
09 May 2011
Ā 



9 May 2011

Ā 

For immediate release

Biome Technologies plc

Ā ("Biome" or "the Company")

Director/PDMR Shareholding

Biome was notified on 6 May 2011 of the following purchases by directors.

John F Standen, non-executive Chairman, purchased 1,463,118 ordinary shares at 0.24 pence per share on 6 May 2011.Ā Following this transaction, John Standen's total shareholding in Biome is 25,708,168 ordinary shares, representing 0.44% of the ordinary issued share capital of the Company.

Paul Mines, Chief Executive, purchased 1,105,583 ordinary shares at 0.24 pence per share on 6 May 2011.Ā Following this transaction, Paul Mines' total shareholding in Biome is 50,403,192 ordinary shares, representing 0.86% of the ordinary issued share capital of the Company. In addition, Paul Mines has unexercised options over 144,372,636 ordinary shares in aggregate. Paul Mines also has an interest in the Company's shares through his participation in the Company's Public Equity Plan (further information is set out in the Company's Annual Report and Financial Statements).

Ā 

- Ends -

Ā 

Ā 

For further information please contact:

Ā 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Sue Bygrave, Group Finance Director

www.biometechnologiesplc.com Tel: +44 (0) 2380 867 100

Ā 

Ā 

Daniel Stewart & Company plc

Oliver Rigby (Nomad)

Martin Lampshire (Broker)

www.danielstewart.co.uk Tel: +44 (0) 20 7776 6550

Ā 

First Columbus

John Nuttall/Chris Crawford/Kelly Gardiner

www.first-columbus.com Tel: +44 (0) 20 3002 2070

Ā 

Ā 

Financial Dynamics

Oliver Winters Tel: +44 (0) 20 7831 3113

Ā 

Ā 

Notes to Editors

Ā 

Admitted to AIM in July 2010, the activities of Biome operate in two divisions; Bioplastics and Stanelco RF Technologies. Both divisions are underpinned by the Group's skills in the commercialisation and development of innovative technology.

Ā 

The Group's core strategy is to develop and broaden its bioplastics business organically and is engaged with a variety of large-scale international customers and partners on a number of key commercial and development partnerships. These target applications in the food, horticulture and the electronics markets, amongst others, further enhance the Group's existing and new product development.

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
RDSLFFFIETITIIL
Date   Source Headline
11th Apr 20057:00 amRNSRe Agreement
7th Apr 20057:00 amRNSRe Agreement
6th Apr 200512:41 pmRNSAdditional Listing
24th Mar 20057:00 amRNSRe Contract
22nd Mar 20054:49 pmRNSAnnual Report and Accounts
21st Mar 20057:02 amRNSStatement on High Court
1st Mar 20057:01 amRNSUpdate re. trials with Asda
28th Feb 20057:00 amRNSFinal Results
23rd Feb 20054:45 pmRNSAdditional Listing
9th Feb 20053:16 pmRNSAgreement and Placing
8th Feb 20057:00 amRNSUpdate re. trials with Asda
31st Jan 20059:09 amRNSRe. Agreement
25th Jan 20057:00 amRNSDirectorate Change
17th Jan 200511:44 amRNSAdditional Listing
4th Jan 200511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.